Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270707 · ClinicalTrials.gov registry record
HyperArc Registry Study
A clinical trial, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- 968
- Enrollment target
NCT05270707: Completed study, sponsored by Varian, a Siemens Healthineers Company.
NCT05270707 is a clinical trial that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 968 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05270707 has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- 968 participants
- Enrollment target
Study Summary
The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.
Primary Outcome
Survival
Interventions
- RADIATION Stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 968 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2025-03-31 |
What the finished NCT05270707 record still lists
NCT05270707 is an observational study that tracks outcomes without assigning an intervention. The registered 968 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic radiosurgery is the first listed.
NCT05270707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05270707 about?
NCT05270707 is a clinical study titled "HyperArc Registry Study". The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.
What is the current status of trial NCT05270707?
This trial is currently completed. The enrollment target is 968 participants. The study started on 2022-03-31. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT05270707?
The interventions under investigation include: Stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT05270707?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05354141 · 970 participants · Phase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- NCT06948422 · 974 participants · Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI